Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.

A Hauschild; U Trefzer; C Garbe; KC Kaehler; Selma Ugurel-Becker; F Kiecker; T Eigentler; H Krissel; A Schott; D Schadendorf

doi:10.1097/CMR.0b013e328307c248

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.

A Hauschild
, U Trefzer
, C Garbe
, KC Kaehler
, Selma Ugurel-Becker
, F Kiecker
, T Eigentler
, H Krissel
, A Schott
, D Schadendorf

Research output: Contribution to journal › Research article

66 Citations (Web of Science)

Original language	English
Journal	Melanoma Research
DOIs	https://doi.org/10.1097/CMR.0b013e328307c248
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

DOI

10.1097/CMR.0b013e328307c248

Links

Cite this

Hauschild, A., Trefzer, U., Garbe, C., Kaehler, KC., Ugurel-Becker, S., Kiecker, F., Eigentler, T., Krissel, H., Schott, A., & Schadendorf, D. (2008). Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma. Melanoma Research. https://doi.org/10.1097/CMR.0b013e328307c248

@article{2ff3911537504d6590625937d551dbdd,

title = "Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-\{4-[(2-aminophenyl)-carbamoyl]-benzyl\}-carbamate in pretreated metastatic melanoma.",

author = "A Hauschild and U Trefzer and C Garbe and KC Kaehler and Selma Ugurel-Becker and F Kiecker and T Eigentler and H Krissel and A Schott and D Schadendorf",

year = "2008",

doi = "10.1097/CMR.0b013e328307c248",

language = "English",

journal = "Melanoma Research",

issn = "0960-8931",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.

AU - Hauschild, A

AU - Trefzer, U

AU - Garbe, C

AU - Kaehler, KC

AU - Ugurel-Becker, Selma

AU - Kiecker, F

AU - Eigentler, T

AU - Krissel, H

AU - Schott, A

AU - Schadendorf, D

PY - 2008

Y1 - 2008

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000257896900006

UR - https://pubmed.ncbi.nlm.nih.gov/18626312

U2 - 10.1097/CMR.0b013e328307c248

DO - 10.1097/CMR.0b013e328307c248

M3 - Research article

C2 - 18626312

SN - 0960-8931

JO - Melanoma Research

JF - Melanoma Research

ER -